🇺🇸 Berotec in United States
1,136 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 1,136
Most-reported reactions
- Dyspnoea — 270 reports (23.77%)
- Asthma — 163 reports (14.35%)
- Drug Ineffective — 123 reports (10.83%)
- Fatigue — 120 reports (10.56%)
- Pneumonia — 119 reports (10.48%)
- Pyrexia — 81 reports (7.13%)
- Malaise — 70 reports (6.16%)
- Cough — 68 reports (5.99%)
- Asthmatic Crisis — 64 reports (5.63%)
- Pain — 58 reports (5.11%)
Other Other approved in United States
Frequently asked questions
Is Berotec approved in United States?
Berotec does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Berotec in United States?
Taiwan Otsuka Pharm. Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.